Bayer AG
Bayer AG (BAYN.SW) Stock Competitors & Peer Comparison
See (BAYN.SW) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BAYN.SW | CHF 35.57 | -3.77% | 36.3B | -11.13 | -CHF 3.32 | +0.28% |
| LLY.SW | CHF 720.00 | -7.69% | 554.8B | 39.60 | CHF 18.18 | +0.68% |
| RO.SW | CHF 324.00 | +0.93% | 257.1B | 20.11 | CHF 16.06 | +3.14% |
| ROG.SW | CHF 322.30 | +0.50% | 256.6B | 20.07 | CHF 16.06 | +3.04% |
| NOVN.SW | CHF 119.98 | +0.38% | 227.3B | 21.20 | CHF 5.62 | +3.11% |
| GSK.SW | CHF 19.98 | N/A | 101.6B | 18.76 | CHF 1.07 | N/A |
| COPN.SW | CHF 80.40 | -0.50% | 1.3B | -381.90 | -CHF 0.21 | +2.39% |
Stock Comparison
BAYN.SW vs LLY.SW Comparison April 2026
BAYN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BAYN.SW stands at 36.3B. In comparison, LLY.SW has a market cap of 554.8B. Regarding current trading prices, BAYN.SW is priced at CHF 35.57, while LLY.SW trades at CHF 720.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BAYN.SW currently has a P/E ratio of -11.13, whereas LLY.SW's P/E ratio is 39.60. In terms of profitability, BAYN.SW's ROE is -0.12%, compared to LLY.SW's ROE of +0.98%. Regarding short-term risk, BAYN.SW and LLY.SW have similar daily volatility (0.00).Check LLY.SW's competition here